Skip to content

Why did humans lose the ability to produce vitamin C?

5 min read

Over 60 million years ago, a single disabling genetic mutation occurred in the common ancestor of all anthropoid primates, rendering our lineage unable to produce its own vitamin C. This remarkable biological change explains why humans are among the few species that depend entirely on their diet to fulfill their vitamin C requirements.

Quick Summary

A non-functional mutation in the GULO gene, which occurred in ancestral primates, caused the loss of vitamin C synthesis. This trait persisted because a diet rich in fruits provided sufficient ascorbic acid, negating selective pressure against the mutation. Recent theories also propose potential evolutionary benefits, such as defense against certain parasites, and adaptations in cellular uptake.

Key Points

  • GULO Gene Mutation: Humans cannot produce vitamin C due to a genetic mutation that inactivated the L-gulonolactone oxidase (GULO) gene millions of years ago.

  • Neutral Selection Hypothesis: An ancestral diet rich in vitamin C from fruits meant the mutation was not a disadvantage and was passed down through generations.

  • Parasite Resistance Theory: Recent findings suggest that relying on dietary vitamin C might offer an evolutionary advantage, possibly by helping to combat certain parasitic infections.

  • Metabolic Efficiency: The loss of internal production coincided with the development of a highly efficient recycling system for vitamin C, reducing daily requirements.

  • Consequence of Loss: This genetic change makes humans susceptible to scurvy and dependent on diet for vitamin C, highlighting the importance of balanced nutrition.

  • Shared Primate Trait: The same GULO gene inactivation is present across all higher primates, suggesting a common evolutionary history.

In This Article

The Genetic Cause: A Disabled GULO Gene

The fundamental reason why humans cannot produce vitamin C is a genetic malfunction. The final enzyme in the vitamin C synthesis pathway, L-gulonolactone oxidase (GULO), is non-functional in humans. This enzyme is required to convert L-gulonolactone into ascorbic acid, but a series of mutations in the GULO gene over millions of years has resulted in a non-functional copy known as a pseudogene. This critical genetic change is a hallmark of our shared ancestry with other higher primates, including chimpanzees, gorillas, and macaques, which also possess this inactivated GULO pseudogene.

The Birth of a Pseudogene

The mutation in the GULO gene is believed to have occurred in an ancestral primate approximately 45 to 62 million years ago, after the lineage split from prosimians like lemurs, which still retain a functional GULO gene. The gene is heavily degraded in humans, with deletions and insertions causing a frame-shift and premature stop codons, making it incapable of producing the necessary enzyme. The permanence of this mutation across higher primates serves as a powerful testament to common descent. The fact that other species that also lost this ability, such as guinea pigs and some bats, have different mutations in the same gene, provides compelling evidence of independent evolutionary events.

The Evolutionary Context: Why the Trait Persisted

The loss of such a vital metabolic function seems counterintuitive from an evolutionary perspective. However, several hypotheses, likely intertwined, explain why this trait was not selected against and became fixed in the primate lineage.

The 'Ascorbate-Rich Diet' Hypothesis

For many years, the most accepted theory was that the mutation was essentially neutral. This hypothesis suggests that because ancestral primates lived in tropical environments with an abundant supply of fruits and vegetables, which are naturally rich in vitamin C, the internal synthesis of the vitamin was no longer metabolically necessary. In this scenario, a mutation disabling the GULO gene would not have conferred a significant survival disadvantage, allowing it to spread through the population via genetic drift without being eliminated by natural selection. This explains why our primate relatives, who maintain a fruit-heavy diet, also possess this genetic 'defect' but do not suffer from scurvy in the wild.

The 'Parasite Resistance' Hypothesis

In recent years, alternative theories have emerged, suggesting the loss of vitamin C synthesis may have provided a hidden evolutionary advantage. One such theory proposes that lower, fluctuating levels of vitamin C may have provided better protection against parasites. For example, studies on schistosome flatworms showed that they reproduce more when provided with extra vitamin C. By becoming dependent on dietary intake, humans and other primates experience varying levels of vitamin C, which may have given them an edge in combating specific parasitic infections. This suggests the loss of the gene was not merely a neutral event but a beneficial trade-off.

The 'Recycling' and 'Metabolic Efficiency' Hypotheses

Another proposed advantage relates to metabolic efficiency and a more sophisticated recycling system. Species that lost vitamin C synthesis, including humans, developed a highly efficient mechanism involving glucose transporter 1 (Glut-1) on red blood cells. This system recycles the oxidized form of vitamin C (dehydroascorbate) back into its usable form (ascorbic acid), significantly reducing the body's daily requirement. This recycling process is energetically more economical than synthesizing the vitamin from scratch. This adaptation would have been a massive advantage during periods of food scarcity, improving survival rates and providing a strong selective pressure for the loss of internal production.

Comparison of Vitamin C Synthesis in Different Species

Feature Humans & Higher Primates Guinea Pigs Most Mammals (e.g., Rats, Dogs) Fruit Bats
GULO Gene Status Inactivated (Pseudogene) Inactivated (Pseudogene) Functional and Active Inactivated (Pseudogene) in many, but functional in some
Ability to Synthesize No (Relies on diet) No (Relies on diet) Yes (Synthesizes own) No (Relies on diet) in many, some can
Location of Synthesis N/A N/A Liver N/A (for non-synthesizers)
Primary Cause of Deficiency Dietary inadequacy Dietary inadequacy Rare, usually due to genetic anomaly or disease Dietary inadequacy
Development of Scurvy Yes, if dietary intake is insufficient Yes, if dietary intake is insufficient No, under normal conditions Yes, if dietary intake is insufficient

Consequences for Modern Humans

The loss of our endogenous vitamin C production capacity has had profound implications for human health. The most well-known consequence is scurvy, a potentially fatal disease caused by severe vitamin C deficiency, historically rampant among sailors on long voyages. In modern times, while widespread scurvy is rare in developed nations, low-level vitamin C deficiency (hypovitaminosis C) is still relatively common, particularly among certain at-risk groups. These include individuals with poor diets, chronic alcohol users, and the elderly. The need for consistent dietary intake makes us vulnerable to deficiencies if our food supply becomes inadequate.

The Importance of Dietary Vitamin C

Unlike most animals, we cannot store significant amounts of vitamin C in our bodies, necessitating a regular dietary supply. It is a powerful antioxidant, crucial for immune function, iron absorption, and the synthesis of collagen, which forms connective tissues, skin, and bones. A sufficient intake is vital for wound healing and overall health. This dependence underscores the importance of a balanced, nutritious diet rich in fruits and vegetables. For a deeper look into the physiological impacts, the National Institutes of Health provides a comprehensive health professional fact sheet on Vitamin C.

Conclusion: A Neutral, or Advantageous, Evolutionary Journey

Ultimately, the answer to why humans lost the ability to produce vitamin C is found in our ancient genetic past and the subtle selective pressures of our ancestral environment. The inactivation of the GULO gene, occurring tens of millions of years ago, was likely enabled by an abundant dietary source of the vitamin, allowing this mutation to persist. Newer research suggests it may not have been a purely neutral event but could have offered selective advantages related to parasite resistance and a more efficient metabolic system. Regardless of the exact balance of factors, this evolutionary change has permanently altered our physiology, making a steady intake of vitamin C through diet an essential requirement for human survival and health.

Frequently Asked Questions

The gene responsible for the final step in vitamin C synthesis in most animals is the L-gulonolactone oxidase (GULO) gene. In humans, this gene has been inactivated by mutations and exists as a non-functional pseudogene.

No. Due to the genetic mutation in the GULO gene, no humans have the ability to produce their own vitamin C. This is a trait shared by all higher primates.

The mutation that led to the loss of vitamin C production occurred in a common ancestor of all higher primates approximately 45 to 62 million years ago, making it an ancient evolutionary event.

Scurvy is a disease caused by a severe deficiency of vitamin C. Since humans cannot produce their own, they are vulnerable to scurvy if their diet lacks sufficient vitamin C for an extended period.

Yes. In addition to humans and other higher primates, other animals such as guinea pigs, capybaras, and some species of bats and fish have independently lost the ability to synthesize vitamin C.

While unlikely in humans, the GULO gene has been shown to be reactivated in some bat species during evolution, suggesting that these genetic changes are not always permanent across all species.

While the loss is often attributed to a neutral mutation, some theories suggest possible evolutionary advantages. These include better defense against certain parasites and a more energy-efficient vitamin C recycling system.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.